Table 1.
Immune checkpoint drugs and associated targets
| Drug name | Immune checkpoint target |
|---|---|
| Ipilimumab | CTLA-4 |
| Tremelimumab | CTLA-4 |
| Pembrolizumab | PD-1 |
| Nivolumab | PD-1 |
| Avelumab | PD-L1 |
| Durvalumab | PD-L1 |
| Atezolizumab | PD-L1 |
CTLA-4 cytotoxic T lymphocyte-associated antigen 4, PD-1 programmed cell death 1, PD-L1 programmed cell death ligand 1